-
Company Insights
Innovation and Patenting activity of Better Collective A/S Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Better Collective A/S Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Riverside Invt – Queensbridge Collective Mixed-Use Tower – North Carolina
Equip yourself with the essential tools needed to make informed and profitable decisions with our Riverside Invt – Queensbridge Collective Mixed-Use Tower – North Carolina report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough understanding of...
-
Company Insights
Innovation and Patenting activity of Suofeiya Home Collection Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Suofeiya Home Collection Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Product Insights
NewLikelihood of Approval Analysis for Malignant Pleural Effusion
Overview How likely is it that the drugs in Malignant Pleural Effusion will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malignant Pleural Effusion Overview Malignant pleural effusion is a condition in...
-
Sector Analysis
NewPropylene Market Analysis and Forecast by Products, Capacity Additions, Top Countries and Active and Upcoming Projects to 2030
Propylene Market Report Overview Propylene is a key petrochemical with diverse applications spanning solvents, propellants, chemical intermediaries, and polymer production. China, the US, and South Korea collectively accounted for over 58% of the global propylene supply in 2023. The propylene market has been growing steadily and is projected to grow at a CAGR of more than 3% during 2023-2030. The propylene market report offers a comprehensive understanding of the key trends influencing the industry. The report also provides opportunities in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Inobrodib in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Inobrodib in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Inobrodib in Refractory Multiple Myeloma Drug Details: Inobrodib (CCS-1477) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Inobrodib in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Inobrodib in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Inobrodib in Relapsed Multiple Myeloma Drug Details: Inobrodib (CCS-1477) is under...
-
Sector Analysis
NewSecondhand Selling – Shopping Trends and Consumer Insights, 2024
Secondhand Selling Market Overview The secondhand market is constrained by concerns about the quality of secondhand goods, particularly, from consumers in Spain, Italy, and China. However, cost is one of the factors driving secondhand clothing & footwear buying, with more than 60% of consumers globally excluding China. China is majorly focusing on getting access to vintage, limited-edition, or unique items including all the other countries. Owing to this, Chinese consumers prefer items secondhand as they are more affordable. Buy the...
-
Sector Analysis
NewMexico Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast, 2023-2028
Following a strong overall annual growth of 15.6% in 2023, GlobalData expects the Mexican construction industry to decline by 4.5% in 2024 before declining 3.7% in 2025. This trend will be driven by a high base effect after significant growth in 2023, as well as challenges like high inflation – causing building materials and wages to rise, and cancellation of construction projects. For example, in February 2024, the development of 35 wind power generation, collectively worth MXN100.8 billion ($5.8 billion),...
-
Thematic Analysis
NewWeb3 – Thematic Intelligence
Web3 is an ideology that refers to the next iteration of the internet built on blockchain. It promises a mix of peer-to-peer (P2P) communication channels and decentralized governance, leading the internet’s transition from an information-centric model to a user-centric model. Web3 aims to give users the ability to create, own, and monetize their content and manage the use of their data. This will be stored on blockchains instead of on third-party servers.